MW5076A1 - Pharmacologicalle active compounds - Google Patents
Pharmacologicalle active compoundsInfo
- Publication number
- MW5076A1 MW5076A1 MW50/76A MW5076A MW5076A1 MW 5076 A1 MW5076 A1 MW 5076A1 MW 50/76 A MW50/76 A MW 50/76A MW 5076 A MW5076 A MW 5076A MW 5076 A1 MW5076 A1 MW 5076A1
- Authority
- MW
- MALAWI
- Prior art keywords
- pharmacologicalle
- active compounds
- compounds
- active
- pharmacologicalle active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5300175 | 1975-12-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MW5076A1 true MW5076A1 (en) | 1978-02-08 |
Family
ID=10466233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MW50/76A MW5076A1 (en) | 1975-12-29 | 1976-11-22 | Pharmacologicalle active compounds |
Country Status (37)
| Country | Link |
|---|---|
| JP (1) | JPS5283388A (xx) |
| AR (1) | AR222290A1 (xx) |
| AT (1) | AT360024B (xx) |
| AU (1) | AU508123B2 (xx) |
| BE (1) | BE849810A (xx) |
| BG (1) | BG29722A3 (xx) |
| CA (1) | CA1073458A (xx) |
| CH (1) | CH631981A5 (xx) |
| CS (1) | CS203995B2 (xx) |
| DD (1) | DD128588A5 (xx) |
| DE (1) | DE2658267A1 (xx) |
| DK (1) | DK587076A (xx) |
| EG (1) | EG12439A (xx) |
| ES (1) | ES454656A1 (xx) |
| FI (1) | FI62668C (xx) |
| FR (1) | FR2336935A1 (xx) |
| GR (1) | GR62441B (xx) |
| HU (1) | HU175171B (xx) |
| IE (1) | IE45082B1 (xx) |
| IL (1) | IL51040A (xx) |
| IT (2) | IT1124740B (xx) |
| LU (1) | LU76481A1 (xx) |
| MW (1) | MW5076A1 (xx) |
| MX (1) | MX5119E (xx) |
| NL (1) | NL7614538A (xx) |
| NO (1) | NO146396C (xx) |
| NZ (1) | NZ182759A (xx) |
| OA (1) | OA05526A (xx) |
| PH (1) | PH14723A (xx) |
| PL (1) | PL104376B1 (xx) |
| PT (1) | PT65949B (xx) |
| RO (1) | RO72475A (xx) |
| SE (1) | SE431544B (xx) |
| SU (1) | SU791235A3 (xx) |
| YU (1) | YU311676A (xx) |
| ZA (1) | ZA767198B (xx) |
| ZM (1) | ZM14376A1 (xx) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ186511A (en) | 1977-03-19 | 1980-11-14 | Smith Kline French Lab | 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones |
| IL56265A (en) * | 1977-12-28 | 1982-08-31 | Om Lab Sa | Process for preparing imidazolyl methylthio guanidine derivatives and a novel intermediate therefor |
| IN151188B (xx) * | 1978-02-13 | 1983-03-05 | Smith Kline French Lab | |
| US4539207A (en) * | 1978-02-13 | 1985-09-03 | Smith Kline & French Laboratories Limited | Pyrimidine compounds |
| AU527202B2 (en) * | 1978-04-11 | 1983-02-24 | Smith Kline & French Laboratories Limited | 2-aminopyrimidones |
| ZA792607B (en) * | 1978-05-30 | 1980-07-30 | Smith Kline French Lab | Nitro compounds |
| ZA793392B (en) * | 1978-07-15 | 1980-08-27 | Smith Kline French Lab | Isoureas and isothioureas |
| US4309435A (en) | 1978-10-16 | 1982-01-05 | Imperial Chemical Industries Ltd. | Antisecretory guanidine derivatives and pharmaceutical compositions containing them |
| US4374836A (en) | 1978-10-16 | 1983-02-22 | Imperial Chemical Industries Ltd. | Antisecretory heterocyclic derivatives, process for their manufacture and pharmaceutical compositions containing them |
| US4496567A (en) * | 1978-11-13 | 1985-01-29 | Smith Kline & French Laboratories Limited | Phenyl alkylaminopyrimidones |
| US4521418A (en) * | 1979-02-21 | 1985-06-04 | Smith Kline & French Laboratories Limited | Guanidinothiazolyl derivatives |
| US4255428A (en) | 1979-03-24 | 1981-03-10 | Smith Kline & French Laboratories Limited | 5-(Hydroxypyridylalkyl)-4-pyrimidones |
| JPS55133379A (en) * | 1979-04-05 | 1980-10-17 | Smith Kline French Lab | Pyrimidone compound |
| DE2962542D1 (en) * | 1979-04-11 | 1982-06-03 | Smith Kline French Lab | Pyrimidone derivatives, process for preparing them and pharmaceutical compositions containing them |
| JPS55145683A (en) * | 1979-04-26 | 1980-11-13 | Smith Kline French Lab | Pyrimidone derivative |
| CA1155842A (en) * | 1980-03-29 | 1983-10-25 | Thomas H. Brown | Compounds |
| ZW21281A1 (en) * | 1980-10-01 | 1981-11-18 | Smith Kline French Lab | Amine derivatives |
| IE53068B1 (en) * | 1981-06-15 | 1988-05-25 | Merck & Co Inc | Diamino isothiazole-1-oxides and -1,1-dioxides as gastic secretion inhibitors |
| PT75074B (en) * | 1981-06-27 | 1986-02-26 | Smith Kline French Lab | Process for preparing certain pyrimidone derivatives and compositions containing them |
| US6417366B2 (en) * | 1999-06-24 | 2002-07-09 | Abbott Laboratories | Preparation of quinoline-substituted carbonate and carbamate derivatives |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1419994A (en) * | 1973-05-03 | 1976-01-07 | Smith Kline French Lab | Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them |
| IN146736B (xx) * | 1975-10-02 | 1979-08-25 | Smith Kline French Lab |
-
1976
- 1976-11-22 MW MW50/76A patent/MW5076A1/xx unknown
- 1976-11-29 NZ NZ182759A patent/NZ182759A/xx unknown
- 1976-12-02 IL IL51040A patent/IL51040A/xx unknown
- 1976-12-02 ZA ZA767198A patent/ZA767198B/xx unknown
- 1976-12-08 CA CA267,385A patent/CA1073458A/en not_active Expired
- 1976-12-09 IT IT30235/76A patent/IT1124740B/it active
- 1976-12-10 PT PT65949A patent/PT65949B/pt unknown
- 1976-12-17 PH PH19265A patent/PH14723A/en unknown
- 1976-12-17 ZM ZM143/76A patent/ZM14376A1/xx unknown
- 1976-12-21 FI FI763664A patent/FI62668C/fi not_active IP Right Cessation
- 1976-12-22 YU YU03116/76A patent/YU311676A/xx unknown
- 1976-12-22 IE IE2814/76A patent/IE45082B1/en unknown
- 1976-12-22 DE DE19762658267 patent/DE2658267A1/de not_active Ceased
- 1976-12-22 GR GR52462A patent/GR62441B/el unknown
- 1976-12-23 CH CH1627876A patent/CH631981A5/de not_active IP Right Cessation
- 1976-12-23 JP JP15611076A patent/JPS5283388A/ja active Granted
- 1976-12-23 AT AT960876A patent/AT360024B/de not_active IP Right Cessation
- 1976-12-23 BE BE173597A patent/BE849810A/xx not_active IP Right Cessation
- 1976-12-27 RO RO7688851A patent/RO72475A/ro unknown
- 1976-12-28 LU LU76481A patent/LU76481A1/xx unknown
- 1976-12-28 HU HU76SI1556A patent/HU175171B/hu unknown
- 1976-12-28 BG BG035033A patent/BG29722A3/xx unknown
- 1976-12-28 SE SE7614620A patent/SE431544B/xx not_active IP Right Cessation
- 1976-12-28 PL PL1976194772A patent/PL104376B1/pl unknown
- 1976-12-28 EG EG803/76A patent/EG12439A/xx active
- 1976-12-28 NO NO764370A patent/NO146396C/no unknown
- 1976-12-29 SU SU762434655A patent/SU791235A3/ru active
- 1976-12-29 FR FR7639465A patent/FR2336935A1/fr active Granted
- 1976-12-29 CS CS768760A patent/CS203995B2/cs unknown
- 1976-12-29 AR AR266049A patent/AR222290A1/es active
- 1976-12-29 ES ES454656A patent/ES454656A1/es not_active Expired
- 1976-12-29 OA OA56028A patent/OA05526A/xx unknown
- 1976-12-29 DD DD7600196703A patent/DD128588A5/xx unknown
- 1976-12-29 NL NL7614538A patent/NL7614538A/xx not_active Application Discontinuation
- 1976-12-29 DK DK587076A patent/DK587076A/da not_active Application Discontinuation
- 1976-12-30 AU AU20976/76A patent/AU508123B2/en not_active Expired
-
1977
- 1977-01-03 MX MX775273U patent/MX5119E/es unknown
-
1979
- 1979-01-05 IT IT7919107A patent/IT7919107A0/it unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS51131843A (en) | Lipidddepleted active compound | |
| GB1539006A (en) | Aminoalkylammonium compound | |
| ZA763652B (en) | Pharmacologically active compounds | |
| JPS57112388A (en) | 1-sulfonylbenzimidazole compound | |
| MW5076A1 (en) | Pharmacologicalle active compounds | |
| ZA765498B (en) | Pharmacologically active compounds | |
| JPS51113900A (en) | Riphamycin compound | |
| ZM9876A1 (en) | Pharmacologically active compounds | |
| ZA765331B (en) | Novel pharmaceutically active compounds | |
| ZA7682B (en) | Pharmacologically active compounds | |
| ZA764267B (en) | Sulphine compounds | |
| GB1544103A (en) | 3-acyloxymethyl-cephem compounds | |
| JPS5223076A (en) | Antiiinflammatory compound | |
| ZA763686B (en) | Pharmacologically active compounds | |
| JPS51143699A (en) | Riphamycin compound | |
| ZA761324B (en) | Pharmaceutically active compounds | |
| JPS51115450A (en) | Phosphorrcontaining compounds | |
| JPS5236665A (en) | 44dithioo33imide azethizinee 22one compound | |
| ZM9776A1 (en) | Pharmacologically active compounds | |
| JPS5231095A (en) | Cephlosporin type compound | |
| JPS5231062A (en) | Perfluoroalkylthionorbornane compound | |
| ZM576A1 (en) | Compounds | |
| JPS5285106A (en) | Carbamateesulphenyllcarbamoylfluoride compounds | |
| PT65839A (en) | Pharmacologically active compounds | |
| ZA762536B (en) | Pharmacologically active compounds |